Comparably accelerated vascularization by preincorporation of aortic fragments and mesenchymal stem cells in implanted tissue engineering constructs.

The demanding need for tissue replacement resulted in manifold approaches for the construction of different tissues. One common problem which hampers the clinical usage of tissue engineering constructs is a limited vascularization. In an attempt to accelerate the vascularization of tissue engineering constructs we compared the usage of bone marrow mesenchymal stem cells (bmMSCs) and fragments derived from the aorta in vivo. Tissue engineering constructs composed of PLGA scaffolds containing Matrigel (n = 8), aortic fragments embedded in Matrigel (n = 8), bmMSCs embedded in Matrigel (n = 8), and aortic fragments embedded in Matrigel combined with bmMSCs (n = 8) were implanted into dorsal skinfold chambers of balb/c mice and analyzed repetitively over 14 days. In all groups a weak inflammatory response was transiently apparent. Vascularization was significantly (p = 0.05) accelerated in bmMSC and aortic fragments containing constructs compared with Matrigel alone, demonstrated by a distinctly increased microvascular density throughout the whole experiment. The combination of bmMSCs and aortic fragments showed no additional effect compared with bmMSCs and aortic fragments alone. The accelerated vascularization and microvascular density of tissue engineering constructs triggered by bmMSCs and aortic fragments is comparable. Thus aortic fragments provide a new promising source for clinical relevant tissue engineering constructs.

[1]  Jun Jiang,et al.  Hypoxic preconditioning attenuates hypoxia/reoxygenation-induced apoptosis in mesenchymal stem cells , 2008, Acta Pharmacologica Sinica.

[2]  Alexander M Seifalian,et al.  The roles of tissue engineering and vascularisation in the development of micro-vascular networks: a review. , 2005, Biomaterials.

[3]  J. Vacanti,et al.  Transplantation of hepatocytes using porous, biodegradable sponges. , 1994, Transplantation proceedings.

[4]  J. Schalkwijk,et al.  Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF. , 2007, Biomaterials.

[5]  Bai Yang,et al.  In vitro and in vivo effects of rat kidney vascular endothelial cells on osteogenesis of rat bone marrow mesenchymal stem cells growing on polylactide-glycoli acid (PLGA) scaffolds , 2007, Biomedical engineering online.

[6]  Lucie Germain,et al.  Inosculation of Tissue‐Engineered Capillaries with the Host's Vasculature in a Reconstructed Skin Transplanted on Mice , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[7]  D. Mooney,et al.  Host Immune Competence and Local Ischemia Affects the Functionality of Engineered Vasculature , 2007, Microcirculation.

[8]  A Krogh,et al.  The number and distribution of capillaries in muscles with calculations of the oxygen pressure head necessary for supplying the tissue , 1919, The Journal of physiology.

[9]  E. Keshet,et al.  Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis , 1992, Nature.

[10]  G. Garcı́a-Cardeña,et al.  Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. , 1997, The Journal of clinical investigation.

[11]  H. Ohgushi,et al.  Experimental Study of Vascularized Tissue-Engineered Bone Grafts , 2006, Plastic and reconstructive surgery.

[12]  J. Fiddes,et al.  The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. , 1991, The Journal of biological chemistry.

[13]  Meijing Wang,et al.  Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B- but not JNK-dependent mechanism. , 2008, American journal of physiology. Cell physiology.

[14]  Nils-Claudius Gellrich,et al.  Consequences of seeded cell type on vascularization of tissue engineering constructs in vivo. , 2009, Microvascular research.

[15]  K. Messmer,et al.  Dorsal skinfold chamber technique for intravital microscopy in nude mice. , 1993, The American journal of pathology.

[16]  Kyongbum Lee,et al.  Vascularization strategies for tissue engineering. , 2009, Tissue engineering. Part B, Reviews.

[17]  Jian Dong,et al.  The repair of large segmental bone defects in the rabbit with vascularized tissue engineered bone. , 2010, Biomaterials.

[18]  S. Houser,et al.  Concentration-dependent inhibition of angiogenesis by mesenchymal stem cells. , 2009, Blood.

[19]  B. Frerich,et al.  In vitro model of a vascular stroma for the engineering of vascularized tissues. , 2001, International journal of oral and maxillofacial surgery.

[20]  A. Aplin,et al.  Aortic rings stimulate inflammatory angiogenesis in a subcutaneous implant in vivo model , 2007, Angiogenesis.

[21]  P. Gouma,et al.  Bioassay Chamber for Angiogenesis with Perfused Explanted Arteries and Electrospun Scaffolding , 2007, Microcirculation.

[22]  J. Vacanti,et al.  Tissue engineering : Frontiers in biotechnology , 1993 .

[23]  D. Goeddel,et al.  Vascular endothelial growth factor is a secreted angiogenic mitogen. , 1989, Science.

[24]  Stefan Langer,et al.  Neovascularization of poly(ether ester) block-copolymer scaffolds in vivo: long-term investigations using intravital fluorescent microscopy. , 2004, Journal of biomedical materials research. Part A.

[25]  M. Reed,et al.  Culture of murine aortic explants in 3-dimensional extracellular matrix: a novel, miniaturized assay of angiogenesis in vitro. , 2007, Microvascular research.

[26]  Paul H Wooley,et al.  Promotion of osteogenesis in tissue‐engineered bone by pre‐seeding endothelial progenitor cells‐derived endothelial cells , 2008, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[27]  M. Menger,et al.  Striated muscle microvascular response to silver implants: A comparative in vivo study with titanium and stainless steel. , 2000, Journal of biomedical materials research.

[28]  Dai Fukumura,et al.  Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature. , 2008, Blood.

[29]  Alexander Schramm,et al.  Angiogenic and inflammatory response to biodegradable scaffolds in dorsal skinfold chambers of mice. , 2006, Biomaterials.

[30]  M. Rücker,et al.  Reduction of inflammatory response in composite flap transfer by local stress conditioning-induced heat-shock protein 32. , 2001, Surgery.

[31]  D. Bezuidenhout,et al.  The dosage dependence of VEGF stimulation on scaffold neovascularisation. , 2008, Biomaterials.

[32]  Gabriel Gruionu,et al.  Rapid Perfusion and Network Remodeling in a Microvascular Construct After Implantation , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[33]  N. Gellrich,et al.  Incorporation of growth factor containing Matrigel promotes vascularization of porous PLGA scaffolds. , 2008, Journal of biomedical materials research. Part A.

[34]  H. Kleinman,et al.  Matrigel: basement membrane matrix with biological activity. , 2005, Seminars in cancer biology.

[35]  J. Vacanti,et al.  Endothelialized Networks with a Vascular Geometry in Microfabricated Poly(dimethyl siloxane) , 2004 .

[36]  Joseph P Vacanti,et al.  An Overview of the Pathology and Approaches to Tissue Engineering , 2002, Annals of the New York Academy of Sciences.

[37]  Peter Carmeliet,et al.  VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[38]  Rui L Reis,et al.  Vascularization in bone tissue engineering: physiology, current strategies, major hurdles and future challenges. , 2010, Macromolecular bioscience.

[39]  Linda G Griffith,et al.  Engineering principles of clinical cell-based tissue engineering. , 2004, The Journal of bone and joint surgery. American volume.

[40]  Robert Langer,et al.  Endothelialized microvasculature based on a biodegradable elastomer. , 2005, Tissue engineering.

[41]  K. Messmer,et al.  Microvascular ischemia-reperfusion injury in striated muscle: significance of "no reflow". , 1992, The American journal of physiology.

[42]  Y. Bae,et al.  Mesenchymal stem cells derived from human adipose tissues favor tumor cell growth in vivo. , 2008, Stem cells and development.

[43]  F. O'Brien,et al.  Evaluation of early healing events around mesenchymal stem cell-seeded collagen–glycosaminoglycan scaffold. An experimental study in Wistar rats , 2011, Oral and Maxillofacial Surgery.

[44]  Hiroshi Yamamoto,et al.  Vascular endothelial growth factor acts as a pericyte mitogen under hypoxic conditions. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[45]  M. Menger,et al.  New experimental approach to study host tissue response to surgical mesh materials in vivo. , 2005, Journal of biomedical materials research. Part A.

[46]  M. Baker,et al.  On-line volume flow rate and velocity profile measurement for blood in microvessels. , 1974, Microvascular research.

[47]  L. Aiello,et al.  Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. , 1996, The Journal of clinical investigation.